Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Busuttil

Showing results (541-550 of 831) with videos related to

Pageof 84
Sort By:
Theranostics|April 16, 2020
PACAP neuropeptide promotes Hepatocellular Protection via CREB-KLF4 dependent autophagy in mouse liver Ischemia Reperfusion InjuryZhengze Xue, Yu Zhang, Yuanxing Liu, et al.
Transplantation Proceedings|February 1, 1993
RS-61443 for treatment-resistant human liver rejectionG B Klintmalm, N L Ascher, R W Busuttil, et al.
Transplantation|September 30, 1998
Liver transplantation in the first three months of lifeE S Woodle, J M Millis, S K So, et al.
Transplantation Proceedings|April 6, 2005
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejectionN V Semiletova, X D Shen, S J Slomowitz, et al.
AJR. American Journal of Roentgenology|September 21, 2006
Intraoperative triple antenna hepatic microwave ablationCaroline J Simon, Damian E Dupuy, David A Iannitti, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitroRichard S Finn, Alexey Aleshin, Judy Dering, et al.
Transplantation|February 27, 2020
Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver TransplantationLaura J Wozniak, Michelle J Hickey, Alvin P Chan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different modelsDouglas G Farmer, Fady Kaldas, Dean Anselmo, et al.
JAMA Surgery|January 29, 2015
Survival benefit of solid-organ transplant in the United StatesAbbas Rana, Angelika Gruessner, Vatche G Agopian, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1987
A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejectionJ O Colonna, L I Goldstein, J J Brems, et al.
Pageof 84

Showing results (541-550 of 831) with videos related to

Sort By:
Pageof 84
Theranostics|April 16, 2020
PACAP neuropeptide promotes Hepatocellular Protection via CREB-KLF4 dependent autophagy in mouse liver Ischemia Reperfusion InjuryZhengze Xue, Yu Zhang, Yuanxing Liu, et al.
Transplantation Proceedings|February 1, 1993
RS-61443 for treatment-resistant human liver rejectionG B Klintmalm, N L Ascher, R W Busuttil, et al.
Transplantation|September 30, 1998
Liver transplantation in the first three months of lifeE S Woodle, J M Millis, S K So, et al.
Transplantation Proceedings|April 6, 2005
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejectionN V Semiletova, X D Shen, S J Slomowitz, et al.
AJR. American Journal of Roentgenology|September 21, 2006
Intraoperative triple antenna hepatic microwave ablationCaroline J Simon, Damian E Dupuy, David A Iannitti, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitroRichard S Finn, Alexey Aleshin, Judy Dering, et al.
Transplantation|February 27, 2020
Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver TransplantationLaura J Wozniak, Michelle J Hickey, Alvin P Chan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different modelsDouglas G Farmer, Fady Kaldas, Dean Anselmo, et al.
JAMA Surgery|January 29, 2015
Survival benefit of solid-organ transplant in the United StatesAbbas Rana, Angelika Gruessner, Vatche G Agopian, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1987
A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejectionJ O Colonna, L I Goldstein, J J Brems, et al.
Pageof 84